Bharat Immunologicals & Biologicals Corporation Limited (BOM:524663)

BOM:524663 Revenue

Bharat Immunologicals & Biologicals Corporation had revenue of 76.50M INR in the twelve months ending September 30, 2023, down -89.99% year-over-year. In the fiscal year ending March 31, 2023, Bharat Immunologicals & Biologicals Corporation had annual revenue of 446.09M, down -43.09%.

• Revenue (ttm): 76.50M
• Revenue Growth: -89.99%
• P/S Ratio: 9.81
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 750.47M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2023	446.09M	-337.79M	-43.09%
Mar 31, 2022	783.88M	-69.46M	-8.14%
Mar 31, 2021	853.34M	184.97M	27.68%
Mar 31, 2020	668.37M	-168.09M	-20.10%
Mar 31, 2019	836.46M	488.47M	140.37%

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2023

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 16, 2026

Data Sources Report a data error